GlassScriptPhysician profile
Melanie Murchison
NPI 1487181681
$10,579.06
in general payments reported to CMS, 2019-2025
22 companies · $2,392 in 2025
The $2,392 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,460 · 2022: $2,414 · 2023: $1,928 · 2024: $2,385 · 2025: $2,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,089 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,088.91 |
| Travel and Lodging | $616.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,677.96 | 2021-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $1,284.39 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Curonix LLC | $955.64 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $877.92 | 2022-2023 | Intracept |
| Spinal Simplicity, LLC | $626.37 | 2023-2025 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $244.74 | 2022-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $138.42 | 2023-2025 | Belbuca, Xtampza |
| Vertos Medical, INC. | $135.82 | 2021-2022 | |
| Painteq LLC | $120.00 | 2022 | |
| Mml US, INC. | $109.39 | 2023-2025 | Reactiv8 |
| Stimwave Technologies Incorporated | $77.39 | 2022 | |
| Bioventus LLC | $77.35 | 2022-2024 | Supartz Fx Sodium Hyaluronate |
| Medtronic, INC. | $63.24 | 2024-2025 | Synchromedii, Inceptiv, Vanta Adaptivestim |
| Averitas Pharma INC. | $35.21 | 2025 | Qutenza |
| Spr Therapeutics, INC | $31.40 | 2023 | Sprint Pns System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $25.21 | 2024 | Standard Rf Disposables |
| Redhill Biopharma INC. | $21.22 | 2021 | |
| Depuy Synthes Sales INC. | $19.10 | 2021 | |
| Abbvie INC. | $17.62 | 2023 | |
| Valinor Pharma, LLC | $17.54 | 2025 | Movantik |
| Arbor Pharmaceuticals, INC. | $12.04 | 2021 | |
| Biodelivery Sciences International, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Murchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.